Swiss National Bank
ARIA

Swiss National Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Swiss National Bank’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-285,100
Closed -$3.55M – 2555
2016
Q4 		$3.55M Buy
285,100
+10,100
+4% +$122K 0.01% 1188
2016
Q3 		$3.77M Sell
275,000
-7,800
-3% -$78.3K 0.01% 1091
2016
Q2 		$2.09M Sell
282,800
-11,400
-4% -$85.5K ﹤0.01% 1477
2016
Q1 		$1.81M Buy
294,200
+59,200
+25% +$332K ﹤0.01% 1507
2015
Q4 		$1.47M Hold
235,000
– – ﹤0.01% 1544
2015
Q3 		$1.37M Buy
235,000
+31,100
+15% +$240K ﹤0.01% 1564
2015
Q2 		$1.69M Buy
203,900
+3,600
+2% +$31.8K ﹤0.01% 1425
2015
Q1 		$1.65M Buy
200,300
+4,300
+2% +$31.8K ﹤0.01% 1428
2014
Q4 		$1.35M Hold
196,000
– – 0.01% 1550
2014
Q3 		$1.06M Hold
196,000
– – ﹤0.01% 1630
2014
Q2 		$1.25M Sell
196,000
-8,900
-4% -$61.2K ﹤0.01% 1581
2014
Q1 		$1.65M Buy
204,900
+47,500
+30% +$370K 0.01% 1337
2013
Q4 		$1.07M Hold
157,400
– – ﹤0.01% 1459
2013
Q3 		$2.9M Sell
157,400
-8,200
-5% -$159K 0.01% 805
2013
Q2 		$2.9M Buy
+165,600
New +$2.94M 0.01% 792

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Swiss National Bank's ARIA Position: Q1 2017 in Review

Swiss National Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 285,100 shares — an estimated $3.55M sold.

Swiss National Bank first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $3.77M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Swiss National Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Swiss National Bank sold 285,100 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $3.55M.
  • Swiss National Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Swiss National Bank's Ariad Pharmaceuticals Inc position peaked at $3.77M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Swiss National Bank's 13F filing for Q1 2017, filed 4 May 2017.